These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Severe hyperphosphatemia following phosphate administration for bowel preparation in patients with renal failure: two cases and a review of the literature. Fine A; Patterson J Am J Kidney Dis; 1997 Jan; 29(1):103-5. PubMed ID: 9002537 [TBL] [Abstract][Full Text] [Related]
43. [Severe hyperphosphoremia and hypocalcemia after the administration of a hypertonic sodium phosphate enema]. Oñoro G; de Lama G; Pérez-Martínez A; González-Vicent M Med Intensiva; 2014 May; 38(4):263-4. PubMed ID: 23890987 [No Abstract] [Full Text] [Related]
44. Oral Fleet Phospho-Soda laxative-induced hyperphosphatemia and hypocalcemic tetany in an adult: report of a case. Vukasin P; Weston LA; Beart RW Dis Colon Rectum; 1997 Apr; 40(4):497-9. PubMed ID: 9106703 [TBL] [Abstract][Full Text] [Related]
45. Acute renal failure following oral sodium phosphate bowel preparation: a nationwide case-crossover study. Choi NK; Lee J; Chang Y; Kim YJ; Kim JY; Song HJ; Shin JY; Jung SY; Choi Y; Lee JH; Park BJ Endoscopy; 2014 Jun; 46(6):465-70. PubMed ID: 24770970 [TBL] [Abstract][Full Text] [Related]
46. Is bowel preparation before colonoscopy a risky business for the kidney? Lien YH Nat Clin Pract Nephrol; 2008 Nov; 4(11):606-14. PubMed ID: 18797448 [TBL] [Abstract][Full Text] [Related]
47. Microscopic focal cryptitis associated with sodium phosphate bowel preparation. Wong NA; Penman ID; Campbell S; Lessells AM Histopathology; 2000 May; 36(5):476-8. PubMed ID: 10866530 [No Abstract] [Full Text] [Related]
48. Severe metabolic changes following oral sodium phosphate in a patient of renal cell carcinoma - On dialysis. Lim CT Indian J Pharmacol; 2016; 48(3):327-8. PubMed ID: 27298508 [TBL] [Abstract][Full Text] [Related]
50. Risk of impaired renal function after colonoscopy: a cohort study in patients receiving either oral sodium phosphate or polyethylene glycol. Russmann S; Lamerato L; Marfatia A; Motsko SP; Pezzullo JC; Olds G; Jones JK Am J Gastroenterol; 2007 Dec; 102(12):2655-63. PubMed ID: 17970832 [TBL] [Abstract][Full Text] [Related]
51. Renal risk associated with sodium phosphate medication: safe in healthy individuals, potentially dangerous in others. Hoffmanová I; Kraml P; Anděl M Expert Opin Drug Saf; 2015 Jul; 14(7):1097-110. PubMed ID: 26084636 [TBL] [Abstract][Full Text] [Related]
52. Severe hyperphosphatemia and hypocalcemia caused by bowel preparation for colonoscopy using oral sodium phosphate in end-stage renal disease. Mishra R; Kaufman D; Mattern J; Dutta SK Endoscopy; 2005 Dec; 37(12):1259-60. PubMed ID: 16329033 [No Abstract] [Full Text] [Related]
54. Acute renal failure following oral sodium phosphate bowel preparation in diabetes. Ma RC; Chow CC; Yeung VT; So WY; Kong AP; Tong PC; Cockram CS; Chan JC Diabetes Care; 2007 Jan; 30(1):182-3. PubMed ID: 17192360 [No Abstract] [Full Text] [Related]
55. Patient preferences and side effects experienced with oral bowel preparations versus self-administered phosphate enema. Forster JA; Thomas WM Ann R Coll Surg Engl; 2003 May; 85(3):185-6. PubMed ID: 12831492 [TBL] [Abstract][Full Text] [Related]
56. A life threatening complication after ingestion of sodium phosphate bowel preparation. Woo YM; Crail S; Curry G; Geddes CC BMJ; 2006 Sep; 333(7568):589-90. PubMed ID: 16974014 [No Abstract] [Full Text] [Related]
57. A case of Conn's syndrome revealed after oral sodium phosphate (Fleet) preparation for colonoscopy. Lee R; Storr M; Hershfield NB J Dig Dis; 2010 Apr; 11(2):111-4. PubMed ID: 20402838 [TBL] [Abstract][Full Text] [Related]